Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
Background While concomitant medications can affect the efficacy of immune checkpoint inhibitors (ICIs), few studies have assessed associations of concomitant medications with the occurrence and profile of immune-related adverse events (irAEs).Methods This study assessed associations of concomitant...
Saved in:
| Main Authors: | Tappei Takada, Yukari Uemura, Haruki Kume, Sebastiano Buti, Satoru Taguchi, Taketo Kawai, Katsuhiko Nara, Takehito Yamamoto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/3/e008806.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
Published: (2024-12-01) -
Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis
by: Yusuke Sato, et al.
Published: (2022-02-01) -
Pan‐Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System
by: Sean R. Miller, et al.
Published: (2024-11-01) -
Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
by: Zhiyang Huang, et al.
Published: (2025-02-01) -
Pan-cancer analysis of MET mutation and its association with the efficacy of immune checkpoint blockade
by: Lijin Chen, et al.
Published: (2025-07-01)